Overview
We are currently seeking a Scientist Transcriptomics and Genomics * to strengthen our team in the research and development of innovative immunotherapeutic products. You will work in Tuebingen (Germany) in an interdisciplinary environment...
CatalYm GmbH is a clinical-stage biotechnology company dedicated to advancing cancer treatment through pioneering Visugromab, a recombinant antibody targeting the immunosuppressive cytokine GDF-15. Under physiological conditions, GDF-15 is essential...
Overview
We are currently seeking a Scientist Transcriptomics and Genomics * to strengthen our team in the research and development of innovative immunotherapeutic products. You will work in Tuebingen (Germany) in an interdisciplinary environment...
As a Senior Clinical Scientist you will be joining the world’s largest & most comprehensive clinical research organisation, powered by healthcare intelligence.
o Reviewing patient medical data (both – ongoing per subject and cumulative medical da...
CatalYm GmbH is a clinical-stage biotechnology company dedicated to advancing cancer treatment through pioneering Visugromab, a recombinant antibody targeting the immunosuppressive cytokine GDF-15. Under physiological conditions, GDF-15 is essential...
Are you looking for an excellent opportunity to expand your research experience and to complement your clinical and scientific training?
Team up with a strong partner to support your translational research ambitions! Strengthen your profile throug...
Ihre Aufgaben:
Will assist the leader for clinical aspects of one or more project(s) in any of the Franchise brand(s) and/ or local brands.
Collaborates with other technical and commercial team members to understand project needs and to effe...
CatalYm GmbH is a clinical-stage biotechnology company dedicated to advancing cancer treatment through pioneering Visugromab, a recombinant antibody targeting the immunosuppressive cytokine GDF-15. Under physiological conditions, GDF-15 is essential...
CatalYm GmbH is a clinical-stage biotechnology company dedicated to advancing cancer treatment through pioneering Visugromab, a recombinant antibody targeting the immunosuppressive cytokine GDF-15. Under physiological conditions, GDF-15 is essential...
Overview
We are currently seeking a Scientist Transcriptomics and Genomics * to strengthen our team in the research and development of innovative immunotherapeutic products. You will work in Tuebingen (Germany) in an interdisciplinary environment...